Contribution of an Anti-CEA Fab' scan in the detection of medullary thyroid cancer.
Malamitsi
Julia
J
Department of Nuclear Medicine, Diagnostic and Therapeutic Center Hygeia, Amaroussion, Athens, Greece. j.malamit@hygeia.gr
Kosmidis
Paris A
PA
Papadopoulos
Savvas
S
Petounis
Andreas
A
Linos
Dimitrios A
DA
D000911:Antibodies, Monoclonal; D001707:Biopsy, Needle; D002272:Carcinoembryonic Antigen / Q000097:blood*; D018276:Carcinoma, Medullary / Q000150:complications / Q000000981:diagnostic imaging* / Q000556:secondary; D003287:Contrast Media; D005260:Female; D006044:Goiter, Nodular / Q000097:blood* / Q000209:etiology*; D006801:Humans; D008207:Lymphatic Metastasis; D008875:Middle Aged; D015609:Organotechnetium Compounds; D011877:Radionuclide Imaging; D013961:Thyroid Gland / Q000473:pathology; D013964:Thyroid Neoplasms / Q000150:complications / Q000000981:diagnostic imaging*
D000911:Antibodies, Monoclonal; D002272:Carcinoembryonic Antigen; D003287:Contrast Media; D015609:Organotechnetium Compounds; C114976:technetium Tc-99m arcitumomab